In obesity and type 2 diabetes, chronic hyperglycemia disrupts GI neuron activity by suppressing AMP-activated protein kinase (AMPK) and enhancing mammalian target of rapamycin (mTOR) signaling, leading to impaired nitric oxide (NO)-mediated insulin sensitivity. Here, MTOR is linked to obesity disorder.